Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T(1)-T(2) Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics

The conventional chemotherapeutics could not be traced in vivo and provide timely feedback on the clinical effectiveness of drugs. Methods: In this study, a tumor-penetrating peptide RGERPPR (RGE) modified, Gd-DTPA conjugated, and doxorubicin (DOX) loaded Fe(3)O(4)@SiO(2)@mSiO(2) nanoparticle drug d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lipeng, Yu, Jing, Liu, Yang, Zhou, Jinge, Sun, Lei, Wang, Jing, Zhu, Jianzhong, Peng, Hui, Lu, Weiyue, Yu, Lei, Yan, Zhiqiang, Wang, Yiting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743462/
https://www.ncbi.nlm.nih.gov/pubmed/29290795
http://dx.doi.org/10.7150/thno.21074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743462/
https://www.ncbi.nlm.nih.gov/pubmed/29290795
http://dx.doi.org/10.7150/thno.21074

Ejemplares similares